Telomerase-specific cancer vaccine

Details Telomerase-specific cancer vaccine Telomerase-specific cancer vaccine

C - Chemistry, Metallurgy

12

N

C12N 15/54 (2006.01) A61K 9/127 (2006.01) A61K 38/45 (2006.01) A61P 35/00 (2006.01) C12N 5/08 (2006.01) C12N 9/12 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2368967

Telomerase-specific T-cell antigens are provided, which are useful in generating T-cell responses against telomerase. Formulations of telomerase antigens as vaccines are useful in treating and preventing cancer, using in vivo or ex vivo techniques.

L'invention concerne des antigènes des lymphocytes T spécifiques de la télomerase utiles dans la génération de réponses des lymphocytes T à la télomérase. Les formulations d'antigènes de la télomérase comme vaccins servent à traiter et prévenir le cancer grâce à des techniques in vivo ou ex vivo.

Affiliated with

Also associated with

Rating

Telomerase-specific cancer vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Telomerase-specific cancer vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Telomerase-specific cancer vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1818459